| CD4-transgenic zebrafish reveal tissue-resident Th2-and regulatory T cell–like populations and diverse mononuclear phagocytes CT Dee, RT Nagaraju, EI Athanasiadis, C Gray, L Fernandez del Ama, ... The Journal of Immunology 197 (9), 3520-3530, 2016 | 132 | 2016 |
| Zebrafish: a new companion for translational research in oncology J Barriuso, R Nagaraju, A Hurlstone Clinical Cancer Research 21 (5), 969-975, 2015 | 117 | 2015 |
| IL-10 high producing genotype predisposes HIV infected individuals to TB infection SR Sunder, SR Hanumanth, RT Nagaraju, SKN Venkata, ... Human immunology 73 (6), 605-611, 2012 | 45 | 2012 |
| Enhanced fatty acid scavenging and glycerophospholipid metabolism accompany melanocyte neoplasia progression in zebrafish F Henderson, HR Johnston, AP Badrock, EA Jones, D Forster, ... Cancer research 79 (9), 2136-2151, 2019 | 29 | 2019 |
| Cooperative behaviour and phenotype plasticity evolve during melanoma progression EJ Rowling, Z Miskolczi, R Nagaraju, DJ Wilcock, P Wang, B Telfer, Y Li, ... Pigment cell & melanoma research 33 (5), 695-708, 2020 | 17 | 2020 |
| Early adaptation of colorectal cancer cells to the peritoneal cavity is associated with activation of “stemness” programs and local inflammation J Barriuso, RT Nagaraju, S Belgamwar, B Chakrabarty, GJ Burghel, ... Clinical Cancer Research 27 (4), 1119-1130, 2021 | 12 | 2021 |
| The intestinal microbiota in colorectal cancer metastasis–Passive observer or key player? M Patel, M McAllister, R Nagaraju, SSF Al Badran, J Edwards, AJ McBain, ... Critical Reviews in Oncology/Hematology 180, 103856, 2022 | 10 | 2022 |
| Zebrafish in oncology J Barriuso, R Nagaraju, A Hurlstone Aging (Albany NY) 7 (5), 286, 2015 | 5 | 2015 |
| PARP14 inhibition restores PD-1 immune checkpoint inhibitor response following IFNγ-driven acquired resistance in preclinical cancer models CW Wong, C Evangelou, KN Sefton, R Leshem, W Zhang, V Gopalan, ... Nature Communications 14 (1), 5983, 2023 | 4 | 2023 |
| Defining a role for systemic chemotherapy in local and advanced appendix adenocarcinoma MC Strach, B Chakrabarty, RT Nagaraju, S Mullamitha, M Braun, ... ESMO open 8 (5), 101619, 2023 | 2 | 2023 |
| Cytoreductive surgery and HIPEC in colorectal cancer peritoneal metastases (CRPM): Real-world outcomes in systemic anticancer treatment–naïve patients. N Tinsley, R Nagaraju, S O'Dwyer, M Braun, S Mullamitha, ... Journal of Clinical Oncology 41 (4_suppl), 39-39, 2023 | 1 | 2023 |
| PARP14 inhibition restores PD-1 immune checkpoint inhibitor response following IFNγ-driven adaptive resistance CW Wong, C Evangelou, KN Sefton, R Leshem, K Sergiou, MLF Carro, ... bioRxiv, 2022.11. 18.517143, 2022 | 1 | 2022 |
| CKLF instigates a “cold” microenvironment to promote MYCN-mediated tumor aggressiveness X Qin, A Lam, X Zhang, S Sengupta, JB Iorgulescu, H Ni, S Das, M Rager, ... Science Advances 10 (11), eadh9547, 2024 | | 2024 |
| A tumor-associated chemokine attracts CCR4-expressing CD4+ cells to foster immune repression and tumor aggressiveness in MYCN-driven neuroblastoma X Qin, A Lam, X Zhang, S Sengupta, JB Lorgulescu, S Das, Z Zhou, T Zuo, ... MOLECULAR CANCER THERAPEUTICS 22 (12), 2023 | | 2023 |
| Abstract LB_C20: A tumor-associated chemokine attracts CCR4-expressing CD4+ cells to foster immune repression and tumor aggressiveness in MYCN-driven … X Qin, A Lam, X Zhang, S Sengupta, JB Iorgulescu, S Das, Z Zhou, T Zuo, ... Molecular Cancer Therapeutics 22 (12_Supplement), LB_C20-LB_C20, 2023 | | 2023 |
| PD-27 The use of pre-operative systemic oxaliplatin or irinotecan doublet chemotherapy in colorectal cancer peritoneal metastases (CRPM): Results from a single UK peritoneal … N Tinsley, R Nagaraju, S O'Dwyer, M Braun, S Mullamitha, ... Annals of Oncology 34, S12, 2023 | | 2023 |
| Spatial characterization of immune microenvironment from early onset metastatic colorectal cancer (EOmCRC) showed a dual prognostic role for IDO1 expression RT Nagaraju, J Franczak, M Möhler, E Fontana, A Giraut, L Dirix, ... Cancer Research 83 (7_Supplement), 6770-6770, 2023 | | 2023 |
| 10P Molecular mutations in appendix cancers MC Strach, B Chakrabarty, R Nagaraju, GJ Burghel, H Schlecht, ... ESMO Open 8 (1), 2023 | | 2023 |
| 8O Outcomes for patients with appendix adenocarcinoma and the role of systemic chemotherapy MC Strach, B Chakrabarty, R Nagaraju, S Mullamitha, M Braun, ... ESMO Open 8 (1), 2023 | | 2023 |
| Clinical outcomes of appendix goblet cell adenocarcinoma and role of systemic chemotherapy. MC Strach, B Chakrabarty, R Nagaraju, O Aziz, S O'Dwyer, J Barriuso Journal of Clinical Oncology 41 (4_suppl), 50-50, 2023 | | 2023 |
